Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo

Carrier-free drug self-delivery systems consisting of amphiphilic drug-drug conjugate (ADDC) with well-defined structure and nanoscale features have drawn much attention in tumor drug delivery. Herein, we report a simple and effective strategy to prepare ADDC using derivatives of cisplatin (CP) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lu, Xu, Jiaxi, Xie, Zheng, Song, Faquan, Wang, Xin, Tang, Rupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2021
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8737405/
https://www.ncbi.nlm.nih.gov/pubmed/35027952
http://dx.doi.org/10.1016/j.ajps.2021.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8737405/
https://www.ncbi.nlm.nih.gov/pubmed/35027952
http://dx.doi.org/10.1016/j.ajps.2021.08.001

Ejemplares similares